Metformin versus Insulin for the Treatment of Gestational Diabetes
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Metformin is a logical treatment for women with gestational diabetes mellitus, but randomized trials to assess the efficacy and safety of its use for this condition are lacking. METHODS: We randomly assigned 751 women with gestational diabetes mellitus at 20 to 33 weeks of gestation to open treatment with metformin (with supplemental insulin if required) or insulin. The primary outcome was a composite of neonatal hypoglycemia, respiratory distress, need for phototherapy, birth trauma, 5-minute Apgar score less than 7, or prematurity. The trial was designed to rule out a 33% increase (from 30% to 40%) in this composite outcome in infants of women treated with metformin as compared with those treated with insulin. Secondary outcomes included neonatal anthropometric measurements, maternal glycemic control, maternal hypertensive complications, postpartum glucose tolerance, and acceptability of treatment. RESULTS: Of the 363 women assigned to metformin, 92.6% continued to receive metformin until delivery and 46.3% received supplemental insulin. The rate of the primary composite outcome was 32.0% in the group assigned to metformin and 32.2% in the insulin group (relative risk, 0.99 [corrected]; 95% confidence interval, 0.80 [corrected] to 1.23 [corrected]). More women in the metformin group than in the insulin group stated that they would choose to receive their assigned treatment again (76.6% vs. 27.2%, P<0.001). The rates of other secondary outcomes did not differ significantly between the groups. There were no serious adverse events associated with the use of metformin. CONCLUSIONS: In women with gestational diabetes mellitus, metformin (alone or with supplemental insulin) is not associated with increased perinatal complications as compared with insulin. The women preferred metformin to insulin treatment. (Australian New Zealand Clinical Trials Registry number, 12605000311651.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While individual RCTs support limited efficacy of metformin (73,74) and glyburide (75) in reducing glucose levels for the treatment of GDM, these agents are not recommended as the first-line treatment for GDM because they are known to cross the placenta and data on long-term safety for offspring is of some concern (35).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [73]
In the citing paper
“It was concluded that metformin alone, or with supplemental insulin, was not associated with increased perinatal complications.”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [112]
In the citing paper
“Blood glucose-lowering pharmacological therapy is effective at improving outcomes in women with gestational diabetes whose hyperglycemia does not respond sufficiently to lifestyle therapy (71, 82, 88–90).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [90]
In the citing paper
“Blood glucose-lowering pharmacological therapy is effective at improving outcomes in women with gestational diabetes whose hyperglycemia does not respond sufficiently to lifestyle therapy (71, 82, 88–90).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [89]
In the citing paper
“Glyburide is effective in controlling blood glucose in women with gestational diabetes”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [90]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Dabelea, D., Hanson, R. L., Lindsay, R. S., Pettitt, D. J., Imperatore, G., Gabir, M. M., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2208 · Cited by 1,277
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes
Ben‐Haroush, A., Yogev, Y., & Hod, M. (2004) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00985.x · Cited by 856
Gestational diabetes: The consequences of not treating
Langer, O., Yogev, Y., Most, O., & Xenakis, E. M. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.039 · Cited by 677
Silverman, B. L., Metzger, B. E., Cho, N. H., & Loeb, C. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.611 · Cited by 643
Hoffman, L., Nolan, C., Wilson, J. D., Oats, J. J. N., & Simmons, D. (1998) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb140192.x · Cited by 570
An Increase in the Incidence of Gestational Diabetes Mellitus: Northern California, 1991–2000
Ferrara, A., Kahn, H. S., Quesenberry, C. P., Riley, C., & Hedderson, M. M. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000113623.18286.20 · Cited by 452
Glueck, C. J., Phillips, H., Cameron, D., Sieve-Smith, L., & Wang, P. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01666-6 · Cited by 430
Research works printed but not linked: 3
- Coetzee EJ, 1980, S Afr Med J, 58, 795
- Coetzee EJ, 1984, S Afr Med J, 65, 635
- Gutzin SJ, 2003, Can J Clin Pharmacol, 10, 179
Cited by
Items 201–300 of 1,001
Metformin versus insulin for gestational diabetes mellitus: a meta-analysis
Zhao, L., Sheng, X., Zhou, S., Yang, T., Ma, L., Zhou, Y., & Cui, Y. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12672 · Cited by 63
Salomäki, H., Heinäniemi, M., Vähätalo, L. H., Ailanen, L., Eerola, K., Ruohonen, S. T., Pesonen, U., & Koulu, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115778 · Cited by 63
“diet, insulin or, as recent studies suggest, with metformin [18, 20].”
ResultOwens, L. A., Egan, A. M., Carmody, L., & Dunne, F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3817 · Cited by 63
“217 228 Type 1 diabetes, n (%) 134 (62) 139 (61) Type 2 diabetes, n (%) 83 (38) 89 (39) Age (mean SD), y 31.”
BackgroundMethodInfluentialSun, Y., Liu, L., Zhou, L., Yu, S., Lan, Y., Liang, Q., Liu, J., Cao, A., & Liu, Y. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c14405 · Cited by 63
Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?
Saleh, H. S., Abdelsalam, W. A., Mowafy, H. E., & Abd ElHameid, A. A. (2016) · International Journal of Reproductive Medicine · doi:10.1155/2016/3480629 · Cited by 61
“Rowan et al. 2008 [39] had randomized Australian study performed on women with gestational diabetes between 20 and 33 weeks of pregnancy getting metformin or insulin.”
BackgroundUse of oral anti-diabetic agents in pregnancy: A pragmatic approach
Kalra, S., Gupta, Y., Kalra, B., & Singla, R. (2015) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.150081 · Cited by 61
“, mean body mass index (BMI) of included patients was > 30 kg/m2.[10]”
BackgroundGrivell, R. M., Yelland, L., Deussen, A. R., Crowther, C., & Dodd, J. M. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13777 · Cited by 70
Screening and Management of Gestational Diabetes Mellitus after Bariatric Surgery
Benhalima, K., Minschart, C., Ceulemans, D., Bogaerts, A., der Schueren, B. V., Mathieu, C., & Devlieger, R. (2018) · Nutrients · doi:10.3390/nu10101479 · Cited by 72
“However, the need for supplemental insulin in women on metformin is high and increased risks for neonatal hypoglycaemia and macrosomia have been reported in women treated with glibenclamide [62,63].”
BackgroundNovel Interventions for the Prevention of Preeclampsia
Ma’ayeh, M., Rood, K. M., Kniss, D. A., & Costantine, M. M. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-1026-8 · Cited by 73
Screening and management of gestational diabetes
Benhalima, K., Devlieger, R., & Assche, A. V. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.07.026 · Cited by 78
Gestational diabetes mellitus management with oral hypoglycemic agents
Ryu, R. J., Hays, K. E., & Hebert, M. F. (2014) · Seminars in Perinatology · doi:10.1053/j.semperi.2014.08.012 · Cited by 59
Elizalde-Velázquez, G. A., Gómez‐Oliván, L. M., García-Medina, S., Islas‐Flores, H., Hernández‐Navarro, M. D., & Galar‐Martínez, M. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.131213 · Cited by 63
Metformin: Past, Present, and Future
Chaudhary, S., & Kulkarni, A. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01539-1 · Cited by 68
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
Waugh, N., Royle, P., Clar, C., Henderson, R., Cummins, E., Hadden, D., Lindsay, R., & Pearson, D. (2010) · Health Technology Assessment · doi:10.3310/hta14450 · Cited by 60
McCance, D. R. (2015) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2015.04.009 · Cited by 95
Desai, N., Roman, A., Rochelson, B. L., Gupta, M., Xue, X., Chatterjee, P. K., Tam, H. T., & Metz, C. N. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.05.001 · Cited by 65
Gestational diabetes mellitus: A pragmatic approach to diagnosis and management
Nankervis, A., Price, S., & Conn, J. (2018) · Australian Journal of General Practice · doi:10.31128/ajgp-01-18-4479 · Cited by 59
Gestational diabetes mellitus: Non-insulin management
Magon, N., & Seshiah, V (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.85580 · Cited by 58
“An Australian study (Metformin in Gestational diabetes – MiG study) conducted by Rowan and colleagues included 751 women (371 received metformin, and 378 received insulin) who were randomized between 20 and 33 weeks of pregnancy.[73] The metformin failure rate was 7.”
Management of Gestational Diabetes Mellitus
Oskovi-Kaplan, Z. A., & Ozgu-Erdinc, A. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_552 · Cited by 78
Impact of metformin on reproductive tissues: an overview from gametogenesis to gestation.
Bertoldo, M. J., Faure, M., Dupont, J., & Froment, P. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.06.04 · Cited by 54
“These results have been supported by smaller but comparable studies (8487,100,102).”
BackgroundResultGandhi, P., Bustani, R., Madhuvrata, P., & Farrell, T. J. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.11.018 · Cited by 70
“The advantage of using metformin is that it is cheap, and because it is an oral preparation, is more acceptable to patients, as demonstrated in the MIG trial [8].”
BackgroundMethodResultInfluentialAsistencia a la gestante con diabetes. Guía de práctica clínica actualizada en 2014
Acosta, D., Balsells, M., Ballesteros, M., Bandrés, O., Bartha, J. L., Bellart, J., Chico, A. I., Codina, M., Corcoy, R., Cortázar, A., et al. (2015) · Avances en Diabetología · doi:10.1016/j.avdiab.2014.12.001 · Cited by 80
Metformin for the treatment of gestational diabetes: An updated meta-analysis
Kitwitee, P., Limwattananon, S., Limwattananon, C., Waleekachonlert, O., Ratanachotpanich, T., Phimphilai, M., Nguyen, T. V., & Pongchaiyakul, C. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.017 · Cited by 55
Benhalima, K., Robyns, K., Van Crombrugge, P., Deprez, N., Seynhave, B., Devlieger, R., Verhaeghe, J., Mathieu, C., & Nobels, F. (2015) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-015-0706-x · Cited by 55
Su, D. F., & Wang, X. Y. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.056 · Cited by 57
Metformin Therapy During Pregnancy
Feig, D. S., & Moses, R. G. (2011) · Diabetes Care · doi:10.2337/dc11-1153 · Cited by 57
Liang, H.-L., Ma, S.-J., Xiao, Y.-N., & Tan, H.-Z. (2017) · Medicine · doi:10.1097/md.0000000000007939 · Cited by 57
“87 a,b,f,g,i U Moore et al([30]) United States A C 32 31 NA NA a,b,i,j,l,m,o U Rowan et al([31]) New Zealand/Australia A C 363 370 32.”
BackgroundHypertension in gestational diabetes mellitus: Pathophysiology and long-term consequences
Sibai, B. M., & Ross, M. G. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050903550899 · Cited by 57
Li, G., Zhao, S., Cui, S., Li, L., Xu, Y., & Li, Y. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3566-0 · Cited by 54
“Furthermore, several RCTs comparing the effects of metformin with insulin for GDM have recently reported inconsistent results [25, 29, 30].”
BackgroundResultTieu, J., McPhee, A. J., Crowther, C. A., & Middleton, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007222.pub3 · Cited by 32
Update on Gestational Diabetes
Pridjian, G. C., & Benjamin, T. D. (2010) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2010.02.017 · Cited by 63
Jin, H., Hong, S., Choi, M., Maeng, H., Kim, D., Chung, S., & Shim, C. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9770-5 · Cited by 53
“In addition, although the use of metformin is not yet accepted, evidence is accumulating that it may be a useful treatment for gestational diabetes (11).”
BackgroundBarrett, H. L., Gatford, K. L., Houda, C. M., De Blasio, M. J., McIntyre, H. D., Callaway, L. K., Dekker Nitert, M., Coat, S., Owens, J. A., Hague, W. M., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1097 · Cited by 51
Self-citationThe use of oral hypoglycaemic agents in pregnancy
Holt, R. I. G., & Lambert, K. D. (2014) · Diabetic Medicine · doi:10.1111/dme.12376 · Cited by 50
Gestational Diabetes Mellitus:current knowledge and unmet needs
Koning, S. H., Hoogenberg, K., Lutgers, H. L., van den Berg, P. P., & Wolffenbuttel, B. H. R. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12422 · Cited by 61
“The aim of that study was to compare the results of metformin and insulin treatment in terms of body composition and measures of adiposity in the children of women who participated in the MiG trial.(83,92) Children who were exposed to metformin in utero had larger subscapular and biceps skin folds than the offspring o…”
ResultWu, R., Zhang, Q., & Li, Z. (2023) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2023.2295809 · Cited by 58
Beyuo, T., Obed, S. A., Adjepong-Yamoah, K. K., Bugyei, K. A., Oppong, S. A., & Marfoh, K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125712 · Cited by 48
Kaitu’u‐Lino, T. J., Brownfoot, F., Beard, S., Cannon, P., Hastie, R. M., Nguyen, T. V., Binder, N. K., Tong, S., & Hannan, N. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0188845 · Cited by 50
van Weelden, W., Wekker, V., de Wit, L., Limpens, J., Ijäs, H., van Wassenaer-Leemhuis, A. G., Roseboom, T. J., van Rijn, B. B., DeVries, J. H., & Painter, R. C. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0479-0 · Cited by 51
Ibrahim, M. I., Hamdy, A., Shafik, A., Taha, S., Anwar, M., & Faris, M. A. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-3090-7 · Cited by 55
Fetal Growth and Birth Anthropometrics in Metformin-Exposed Offspring Born to Mothers With PCOS
Hjorth-Hansen, A., Salvesen, Ø., Engen Hanem, L. G., Eggebø, T., Salvesen, K. Å., Vanky, E., & Ødegård, R. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01191 · Cited by 47
Yu, D., Xu, G., Teng, X., Xu, J., Tang, L., Feng, C., Rao, J., Jin, M., & Wang, L. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00865-9 · Cited by 56
“Pairwise meta-analysis showed no significant differences between metformin and inslin, glyburide and insulin or Rowan 2008 Metformin 102.6 (21.6) 93.6 (10.8) −9 (18.7) 174.6 (37.8) 111.6 (10.8) −63 (33.72) 5.7 (0.6) 5.6 (0.5) −0.1 (0.557) Insulin 102.6 (19.8) 91.8 (12.6) −10.8 (17.36) 169.2…”
InfluentialEfficacy and safety of metformin during pregnancy: an update
Paschou, S. Α., Shalit, A., Gerontiti, E., Athanasiadou, K. I., Kalampokas, T., Ψαλτοπούλου, Θ., Lambrinoudaki, I. V., Anastasiou, E., Wolffenbuttel, B. H. R., & Goulis, D. G. (2023) · Endocrine · doi:10.1007/s12020-023-03550-0 · Cited by 60
“Speci-fi cally, the maximum fasting glucose concentrations range from 5.5 to 6.1 mmol/L (100 to 110 mg/dL), and post-prandial concentrations were measured at 1, 1.5 or 2 h with differing limits [8, 9, 26].”
BackgroundResultInfluentialInsulin therapy and fetoplacental vascular function in gestational diabetes mellitus
Sobrevía, L., Salsoso, R., Sáez, T., Sanhueza, C., Pardo, F., & Leiva, A. (2015) · Experimental Physiology · doi:10.1113/expphysiol.2014.082743 · Cited by 52
“However, insulin therapy is still required in a significant number of women treated with these drugs ( 40%; Rowan et al. 2008).”
Cluver, C. A., Walker, S. P., Mol, B. W., Hall, D. R., Hiscock, R. J., Brownfoot, F., Kaitu’u‐Lino, T. J., & Tong, S. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025809 · Cited by 49
Metformin beyond type 2 diabetes: Emerging and potential new indications
Petrie, J. R. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15756 · Cited by 61
Obesity and gestational diabetes
Sathyapalan, T., Mellor, D., & Atkin, S. L. (2010) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2009.09.002 · Cited by 46
Diabetes and the Female Reproductive System
Nandi, A. A., & Poretsky, L. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.007 · Cited by 55
Individualized glycaemic targets and pharmacotherapy in type 2 diabetes
Bailey, C. J., Aschner, P. J., Prato, S. D., LaSalle, J. R., Ji, L., Matthaei, S., & Management, O. B. O. T. G. P. F. E. D. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113490765 · Cited by 51
Type 2 diabetes in pregnancy – An increasing problem
Temple, R., & Murphy, H. R. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.05.011 · Cited by 52
Gestational diabetes mellitus: Multi-disciplinary treatment approaches
Kintiraki, E., & Goulis, D. G. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.025 · Cited by 56
Krstevska, S. S., Bogoev, M. K., Bogoeva, K., Zisovska, E., Samardziski, I., Nakova, V. V., Livrinova, V., Todorovska, I., Sima, A., & Blazevska-Siljanoska, V. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.200 · Cited by 49
“But contrary studies found that metformin may reduce preeclampsia in GDM women by reducing the endothelial activation and maternal inflammatory response to insulin resistance [8][10].”
BackgroundJungheim, E. S., & Odibo, A. O. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.077 · Cited by 51
“2662 Jungheim and Odibo Oral ovulation induction agents potential value of metformin as a maintenance medication for women with PCOS in the pre-, peri-, and postconceptional periods, because they are at high risk for developing gestational diabetes (27).”
BackgroundMethodMetformin for pregnancy and beyond: the pros and cons
Newman, C., & Dunne, F. (2021) · Diabetic Medicine · doi:10.1111/dme.14700 · Cited by 48
Parsons, J., Sparrow, K., Ismail, K., Hunt, K. F., Rogers, H., & Forbes, A. (2018) · Diabetic Medicine · doi:10.1111/dme.13794 · Cited by 49
“GDM management involves an intensive approach of reducing blood glucose to improve pregnancy outcomes, requiring women to make rapid and radical behavioural changes including reducing or altering carbohydrate consumption, increasing physical activity, monitoring blood glucose, and taking diabetes medications [7-9].”
BackgroundGestational Diabetes During and After Pregnancy
Kim, C., & Ferrara, A. M. (2010) · Springer eBooks · doi:10.1007/978-1-84882-120-0 · Cited by 54
Metformin for gestational diabetes mellitus: progeny, perspective, and a personalized approach
Barbour, L. A., & Feig, D. S. (2019) · Diabetes Care · doi:10.2337/dci18-0055 · Cited by 44
“In a recent publication, investigators analyzed 182 offspring at 4 years of age (55% of the total cohort) from two RCTs of women with PCOS (8).”
BackgroundInfluentialFornes, R., Simin, J., Nguyen, M. H., Cruz, G., Crisosto, N., van der Schaaf, M., Engstrand, L., & Brusselaers, N. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00905-6 · Cited by 44
Precision gestational diabetes treatment: a systematic review and meta-analyses
Benham, J. L., Gingras, V., Mclennan, N., Most, J., Yamamoto, J. M., Aiken, C., Ozanne, S. E., Reynolds, R. M., PMDI, A., Tobias, D. K., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00371-0 · Cited by 54
Polycystic Ovary Syndrome and Insulin: Our Understanding in the Past, Present and Future
Mayer, S., Evans, W. S., & Nestler, J. E. (2015) · Women s Health · doi:10.2217/whe.14.73 · Cited by 59
Tertti, K., Eskola, E., Rönnemaa, T., & Haataja, L. (2015) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000230 · Cited by 44
Polycystic Ovary Syndrome: Impact of Lipotoxicity on Metabolic and Reproductive Health
Brennan, K. M., Kroener, L. L., Chazenbalk, G. D., & Dumesic, D. A. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000661 · Cited by 48
He, K., Guo, Q., Ge, J., Li, J., Li, C., & Jing, Z. (2021) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13503 · Cited by 51
The growth hormone–insulin-like growth factor axis in pregnancy
Kaur, H., Muhlhausler, B. S., Roberts, C. T., & Gatford, K. L. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0087 · Cited by 43
Panchaud, A., Rousson, V., Vial, T., Bernard, N., Baud, D., Amar, E., Santis, M. D., Pistelli, A., Dautriche, A., Beau-Salinas, F., et al. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13481 · Cited by 47
Metformin during Pregnancy: Effects on Offspring Development and Metabolic Function
Jorquera, G., Echiburú, B., Crisosto, N., Sotomayor‐Zárate, R., Maliqueo, M. A., & Cruz, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00653 · Cited by 49
Sheng, B., Ni, J., Lv, B., Jiang, G., Lin, X., & Li, H. (2023) · Acta Diabetologica · doi:10.1007/s00592-022-02016-5 · Cited by 50
“We used trim-and-fill NR No Reported § indicates glycemic control is not achieved by maximum metformin dose, and insulin is added * represents the participants are included in the metformin group for pooled analysis Table 1 (continued) Author, year Country Study period Participants Participants enrolled Dose No. of Ne…”
BackgroundInfluentialKang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 84
Obesity in Pregnancy: ACOG Practice Bulletin, Number 230
Sagi‐Dain, L. (2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004527 · Cited by 46
The emerging role of metformin in gestational diabetes mellitus
Gray, S. G., McGuire, T. M., Cohen, N., & Little, P. J. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12893 · Cited by 40
“The investigators reported that most women would be happy to take metformin again in subsequent pregnancies.(38) In 2015, Ainuddin’s group published a randomized, open label”
BackgroundResultInfluentialBrownfoot, F., & Rolnik, D. L. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2024.102481 · Cited by 56
Tůma, P. (2014) · Journal of Chromatography A · doi:10.1016/j.chroma.2014.04.016 · Cited by 40
Oral hypoglycemic agents for gestational diabetes mellitus?
Maymone, A. C., Baillargeon, J.-P., Ménard, J., & Ardilouze, J.-L. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.521740 · Cited by 41
“However, the MiG trial [7] study was not taken into account in these reports.”
BackgroundMethodInfluentialVan Dam, J. M., Garrett, A. J., Schneider, L. A., Hodyl, N. A., Goldsworthy, M. R., Coat, S., Rowan, J. A., Hague, W. M., & Pitcher, J. B. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.04.011 · Cited by 41
Self-citationDysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement
Negrato, C. A., Montenegro, R. M., Mattar, R., Zajdenverg, L., Francisco, R. P. V., Pereira, B. G., Sancovski, M., Torloni, M. R., Dib, S. A., Viggiano, C. E., et al. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-27 · Cited by 53
“trials have shown the safety of metformin during pregnancy [20-22] (B) and of the use of glibenclamide in patients with GDM after the second trimester [23] (B).”
BackgroundAhmadimoghaddam, D., & Štaud, F. (2013) · Reproductive Toxicology · doi:10.1016/j.reprotox.2013.03.001 · Cited by 44
“Low-molecular oral hypoglycemic agents are, herefore, searched for as a “more comfortable” alternative and, ndeed, recent evidence based on trials and meta-analyses show hat GDM can be safely and effectively treated with oral hypolycemic agents such as glyburide or metformin [4–7].”
BackgroundDrugs for gestational diabetes
Donovan, P. J., & McIntyre, D. H. (2010) · Australian Prescriber · doi:10.18773/austprescr.2010.066 · Cited by 40
Metformin prevents macrosomia and neonatal morbidity in gestational diabetes
Hasan, J. A., Karim, N., & Sheikh, Z. (2012) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.283.1686 · Cited by 39
Battin, M. R., Obolonkin, V., Rush, E., Hague, W., Coat, S., & Rowan, J. (2015) · BMC Pediatrics · doi:10.1186/s12887-015-0372-1 · Cited by 37
“Except for a lower proportion of Pacific Island ethnicity, however, this group were not different in baseline characteristics from those in the initial trial [10].”
BackgroundMethodResultSelf-citationDiabetes und Schwangerschaft: Update 2011
Kleinwechter, H. J. (2011) · Der Diabetologe · doi:10.1007/s11428-010-0672-x · Cited by 39
Ruholamin, S., Eshaghian, S., & Allame, Z. (2014) · PubMed Central · Cited by 46
Gestational diabetes: causes and consequences
Lindsay, R. S. (2009) · The British Journal of Diabetes · doi:10.1177/1474651408101644 · Cited by 49
Kruse, B. C., & Vassar, M. B. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.10.007 · Cited by 39
Maternal polycystic ovarian syndrome and early offspring development
Bell, G. A., Sundaram, R., Mumford, S. L., Park, H., Mills, J. L., Bell, E. M., Broadney, M. M., & Yeung, E. H. (2018) · Human Reproduction · doi:10.1093/humrep/dey087 · Cited by 44
Pregestational Diabetes in Pregnancy
Sugrue, R. P., & Zera, C. (2018) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2018.01.002 · Cited by 43
Abolhassani, N., Winterfeld, U., Kaplan, Y. C., Jaques, C., Minder, B., Giovane, C. D., & Panchaud, A. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002919 · Cited by 43
“10 14–16 Metformin is also commonly used for polycystic ovary syndrome (PCOS) associated infertility, a condition affecting 4%–20% of women of reproductive age worldwide.”
Feto-maternal outcomes and Glycemic control in Metforminversus insulin treated Gestational Diabetics
Arshad, R., Khanam, S., SHAIKH, D. F., & Karim, D. N. (2017) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.335.13286 · Cited by 37
The maternal womb: a novel target for cancer prevention in the era of the obesity pandemic?
Simmen, F. A., & Simmen, R. C. M. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328348fc21 · Cited by 39
“…with diet) during preconception and pregnancy to mitigate the negative effects of maternal obesity include metformin, glyburides, and glucagon-like peptide analogs (Rowan et al., 2008; Dhulkotia et al., 2010; Rowan et al., 2010; Shyangdan et al., 2010; Simmons, 2010; Waugh et al., 2010).”
BackgroundTertti, K., Toppari, J., Virtanen, H. E., Sadov, S., & Rönnemaa, T. (2016) · The Review of Diabetic Studies · doi:10.1900/rds.2016.13.59 · Cited by 36
Progesterone Attenuates SIRT1-Deficiency-Mediated Pre-Eclampsia
Pei, J., Liu, Z., Wang, C., Chu, N., Liu, L., Tang, Y., Liu, H., Xiang, Q., Cheng, H., Li, M., et al. (2022) · Biomolecules · doi:10.3390/biom12030422 · Cited by 37
Vokálová, L., van Breda, S. V., Ye, X. L., Huhn, E. A., Than, N. G., Hasler, P., Lapaire, O., Hoesli, I. M., Rossi, S. W., & Hahn, S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00542 · Cited by 36
“In severe cases this may include treatment with insulin or metformin, whilst less severe forms are usually managed by a regimen of diet and exercise (2, 3, 10, 11).”
Paavilainen, E., Tertti, K., Nikkinen, H., Veijola, R., Vääräsmäki, M., Loo, B.-M., Tossavainen, P. H., Rönnemaa, T., & Niinikoski, H. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14589 · Cited by 37
Oral Hypoglycemic Agents in Pregnancy
Refuerzo, J. (2011) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2011.02.013 · Cited by 33
Protective effect of metformin on a rat model of lipopolysaccharide‐induced preeclampsia
Hu, J., Zhang, J., & Zhu, B. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12501 · Cited by 38
Amin, M., Suksomboon, N., Poolsup, N., & Malik, O. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0289-3 · Cited by 40
“Therefore, further studies of metformin were conducted, mostly in comparison with insulin [27, 28] and a few with glyburide [15–17].”
BackgroundTertti, K., Laine, K., Ekblad, U., Rinne, V. M., & Rönnemaa, T. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0570-6 · Cited by 35
Wang, X., Liu, W., Chen, H., & Chen, Q. (2021) · Gynecologic and Obstetric Investigation · doi:10.1159/000515893 · Cited by 40
Goyal, A., Gupta, Y., & Tandon, N. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01210-6 · Cited by 42
“Among oral antihyperglycemic drugs, metformin (dose range 500–2000 mg/day; usual dose 1000 mg/day) is used mainly as an adjuvant to insulin; its use as a primary antihyperglycemic therapy is usually associated with a high secondary failure rate, approximately 46%, as reported in the Metformin in Gestational Diabetes (…”
BackgroundRush, E. C., Bristow, S. M., Plank, L. D., & Rowan, J. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.182 · Cited by 37
Self-citationSilverii, G. A. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15749 · Cited by 33
“105,106 Consistently, in a clinical trial on pregnant women with type 2 diabetes on insulin therapy, adding metformin to insulin was associated with a reduction in maternal weight gain and a lower risk of large-for-gestational-age newborn and caesarean births, in respect to insulin alone; on the…”
Metadata
- Authors
- Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P.
- Affiliations
- Auckland City Hospital (NZ)
- Women's and Children's Hospital (AU)
- Auckland University of Technology (NZ)
- University of Auckland (NZ)
- Christchurch Hospital (NZ)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-05-08
- Volume
- 358
- Issue
- 19
- Pages
- 2003-2015
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2003621575
- Cited by
- 1,291
- References
- 33
- Citations by year
- 2026: 49 · 2025: 60 · 2024: 52 · 2023: 65 · 2022: 63 · 2021: 90 · 2020: 67 · 2019: 66 · 2018: 105 · 2017: 125 · 2016: 68 · 2015: 82 · 2014: 69 · 2013: 62 · 2012: 56
- FWCI
- 78.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, insulin, gestational diabetes mellitus, neonatal hypoglycemia, perinatal complications, maternal glycemic control, postpartum glucose tolerance, treatment acceptability, treatment preferences, neonatal respiratory distress, phototherapy
- MeSH terms
- Adult, Drug Therapy, Combination, Female, Gestational Age, Humans, Hypoglycemia, Hypoglycemic Agents, Infant, Newborn, Insulin, Jaundice, Neonatal, Metformin, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Outcome, Diabetes, Gestational, Patient Satisfaction, Premature Birth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.